- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 723780, 10 pages
Prediction of Effective Drug Combinations by Chemical Interaction, Protein Interaction and Target Enrichment of KEGG Pathways
1Institute of Systems Biology, Shanghai University, Shanghai 200444, China
2College of Information Engineering, Shanghai Maritime University, Shanghai 201306, China
3Key Laboratory of Systems Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
4State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai 201203, China
5Department of Ophthalmology, Shanghai First People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, China
6Beijing Genomics Institute, Shenzhen Beishan Industrial Zone, Shenzhen 518083, China
Received 8 June 2013; Accepted 24 July 2013
Academic Editor: Tao Huang
Copyright © 2013 Lei Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. Jia, F. Zhu, X. Ma, Z. W. Cao, Y. X. Li, and Y. Z. Chen, “Mechanisms of drug combinations: Interaction and network perspectives,” Nature Reviews Drug Discovery, vol. 8, no. 2, pp. 111–128, 2009.
- J. Lehár, A. S. Krueger, W. Avery et al., “Synergistic drug combinations tend to improve therapeutically relevant selectivity,” Nature Biotechnology, vol. 27, pp. 659–666, 2009.
- K. W. Pak, F. Yu, A. Shahangian, G. Cheng, R. Sun, and C.-M. Ho, “Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 13, pp. 5105–5110, 2008.
- T.-C. Chou, “Drug combination studies and their synergy quantification using the chou-talalay method,” Cancer Research, vol. 70, no. 2, pp. 440–446, 2010.
- L. Yang, J. Chen, L. Shi, M. P. Hudock, K. Wang, and L. He, “Identifying unexpected therapeutic targets via chemical-protein interactome,” PLoS ONE, vol. 5, no. 3, Article ID e9568, 2010.
- Z. Wu, X.-M. Zhao, and L. Chen, “A systems biology approach to identify effective cocktail drugs,” BMC Systems Biology, vol. 4, article 7, 2010.
- L. Brouwers, M. Iskar, G. Zeller, V. van Noort, and P. Bork, “Network neighbors of drug targets contribute to drug side-effect similarity,” PLoS ONE, vol. 6, no. 7, Article ID e22187, 2011.
- X.-M. Zhao, M. Iskar, G. Zeller, M. Kuhn, V. van Noort, and P. Bork, “Prediction of drug combinations by integrating molecular and pharmacological data,” PLoS Computational Biology, vol. 7, no. 12, Article ID e1002323, 2011.
- K. J. Xu, J. Song, and X. M. Zhao, “The drug cocktail network,” BMC Systems Biology, vol. 6, supplement 1, article S5, 2012.
- M. Campillos, M. Kuhn, A.-C. Gavin, L. J. Jensen, and P. Bork, “Drug target identification using side-effect similarity,” Science, vol. 321, no. 5886, pp. 263–266, 2008.
- Y. Yamanishi, M. Kotera, M. Kanehisa, and S. Goto, “Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework,” Bioinformatics, vol. 26, no. 12, pp. i246–i254, 2010.
- M. Kuhn, C. von Mering, M. Campillos, L. J. Jensen, and P. Bork, “STITCH: interaction networks of chemicals and proteins,” Nucleic Acids Research, vol. 36, no. 1, pp. D684–D688, 2008.
- L. J. Jensen, M. Kuhn, M. Stark et al., “STRING 8—a global view on proteins and their functional interactions in 630 organisms,” Nucleic Acids Research, vol. 37, no. 1, pp. D412–D416, 2009.
- T. Huang, J. Zhang, Z.-P. Xu et al., “Deciphering the effects of gene deletion on yeast longevity using network and machine learning approaches,” Biochimie, vol. 94, no. 4, pp. 1017–1025, 2012.
- H. Peng, F. Long, and C. Ding, “Feature selection based on mutual information: criteria of Max-Dependency, Max-Relevance, and Min-Redundancy,” IEEE Transactions on Pattern Analysis and Machine Intelligence, vol. 27, no. 8, pp. 1226–1238, 2005.
- L. Breiman, “Random forests,” Machine Learning, vol. 45, no. 1, pp. 5–32, 2001.
- D. Hare and T. Foster, “The Orange Book: the food and drug administration's advice on therapeutic equivalence,” American pharmacy, vol. 30, no. 7, pp. 35–37, 1990.
- Y. Liu, B. Hu, C. Fu, and X. Chen, “DCDB: drug combination database,” Bioinformatics, vol. 26, no. 4, pp. 587–588, 2010.
- M. Venkatesh, V. G. Bairavi, and K. C. Sasikumar, “Generic antibiotic industries: challenges and implied strategies with regulatory perspectives,” Journal of Pharmacy and Bioallied Sciences, vol. 3, no. 1, pp. 101–108, 2011.
- C. Y. Liew, C. Pan, A. Tan, K. X. M. Ang, and C. W. Yap, “QSAR classification of metabolic activation of chemicals into covalently reactive species,” Molecular Diversity, vol. 16, pp. 389–400, 2012.
- A.-B. Haidich, D. Pilalas, D. G. Contopoulos-Ioannidis, and J. Ioannidis, “Most meta-analyses of drug interventions have narrow scopes and many focus on specific agents,” Journal of Clinical Epidemiology, vol. 66, pp. 371–378, 2013.
- M. Kanehisa and S. Goto, “KEGG: Kyoto Encyclopedia of Genes and Genomes,” Nucleic Acids Research, vol. 28, no. 1, pp. 27–30, 2000.
- D. S. Wishart, C. Knox, A. C. Guo et al., “DrugBank: a comprehensive resource for in silico drug discovery and exploration,” Nucleic Acids Research, vol. 34, pp. D668–D672, 2006.
- X. Chen, Z. L. Ji, and Y. Z. Chen, “TTD: therapeutic target database,” Nucleic Acids Research, vol. 30, no. 1, pp. 412–415, 2002.
- C. Steinbeck, C. Hoppe, S. Kuhn, M. Floris, R. Guha, and E. L. Willighagen, “Recent developments of the Chemistry Development Kit (CDK)—an open-source Java library for chemo- and bioinformatics,” Current Pharmaceutical Design, vol. 12, no. 17, pp. 2111–2120, 2006.
- Y. C. Martin, J. L. Kofron, and L. M. Traphagen, “Do structurally similar molecules have similar biological activity?” Journal of Medicinal Chemistry, vol. 45, no. 19, pp. 4350–4358, 2002.
- P. Willett, J. M. Barnard, and G. M. Downs, “Chemical similarity searching,” Journal of Chemical Information and Computer Sciences, vol. 38, no. 6, pp. 983–996, 1998.
- L. J. Jensen, J. Saric, and P. Bork, “Literature mining for the biologist: from information retrieval to biological discovery,” Nature Reviews Genetics, vol. 7, no. 2, pp. 119–129, 2006.
- J. Šarić, L. J. Jensen, R. Ouzounova, I. Rojas, and P. Bork, “Extraction of regulatory gene/protein networks from Medline,” Bioinformatics, vol. 22, no. 6, pp. 645–650, 2006.
- L.-L. Hu, C. Chen, T. Huang, Y.-D. Cai, and K.-C. Chou, “Predicting biological functions of compounds based on chemical-chemical interactions,” PLoS ONE, vol. 6, no. 12, Article ID e29491, 2011.
- L. Chen, W.-M. Zeng, Y.-D. Cai, K.-Y. Feng, and K.-C. Chou, “Predicting anatomical therapeutic chemical (ATC) classification of drugs by integrating chemical-chemical interactions and similarities,” PLoS ONE, vol. 7, no. 4, Article ID e35254, 2012.
- L. Hu, T. Huang, X. Shi, W.-C. Lu, Y.-D. Cai, and K.-C. Chou, “Predicting functions of proteins in mouse based on weighted protein-protein interaction network and protein hybrid properties,” PLoS ONE, vol. 6, no. 1, Article ID e14556, 2011.
- P. Gao, Q. P. Wang, L. Chen, and T. Huang, “Prediction of human genes regulatory functions based on proteinprotein interaction network,” Protein and Peptide Letters, vol. 19, pp. 910–916, 2012.
- T. Huang, P. Wang, Z. Q. Ye et al., “Prediction of deleterious non-synonymous SNPs based on protein interaction network and hybrid properties,” PLoS ONE, vol. 5, no. 7, Article ID e11900, 2010.
- P. Carmona-Saez, M. Chagoyen, F. Tirado, J. M. Carazo, and A. Pascual-Montano, “GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists,” Genome Biology, vol. 8, no. 1, article R3, 2007.
- I. H. Witten and E. Frank, Data Mining: Practical Machine Learning Tools and Techniques, Morgan Kaufmann, 2005.
- L. Chen, K.-Y. Feng, Y.-D. Cai, K.-C. Chou, and H.-P. Li, “Predicting the network of substrate-enzyme-product triads by combining compound similarity and functional domain composition,” BMC Bioinformatics, vol. 11, article 293, 2010.
- P. Baldi, S. Brunak, Y. Chauvin, C. A. F. Andersen, and H. Nielsen, “Assessing the accuracy of prediction algorithms for classification: an overview,” Bioinformatics, vol. 16, no. 5, pp. 412–424, 2000.
- B. W. Matthews, “Comparison of the predicted and observed secondary structure of T4 phage lysozyme,” Biochimica et Biophysica Acta, vol. 405, no. 2, pp. 442–451, 1975.
- T. Fawcett, “An introduction to ROC analysis,” Pattern Recognition Letters, vol. 27, no. 8, pp. 861–874, 2006.
- T.-L. Zhang and Y.-S. Ding, “Using pseudo amino acid composition and binary-tree support vector machines to predict protein structural classes,” Amino Acids, vol. 33, no. 4, pp. 623–629, 2007.
- M. Bhasin and G. P. S. Raghava, “GPCRpred: an SVM-based method for prediction of families and subfamilies of G-protein coupled receptors,” Nucleic Acids Research, vol. 32, pp. W383–W389, 2004.
- N. Huang, H. Chen, and Z. Sun, “CTKPred: an SVM-based method for the prediction and classification of the cytokine superfamily,” Protein Engineering, Design and Selection, vol. 18, no. 8, pp. 365–368, 2005.
- B. Petersen, C. Lundegaard, and T. N. Petersen, “NetTurnP—neural network prediction of beta-turns by use of evolutionary information and predicted protein sequence features,” PLoS ONE, vol. 5, no. 11, Article ID e15079, 2010.
- R. Kohavi, “A study of cross-validation and bootstrap for accuracy estimation and model selection,” San Mateo, pp. 1137–1143, 1995.
- Z. S. He, J. Zhang, X.-H. Shi et al., “Predicting drug-target interaction networks based on functional groups and biological features,” PLoS ONE, vol. 5, no. 3, Article ID e9603, 2010.
- L. Chen, W. M. Zeng, Y. D. Cai, and T. Huang, “Prediction of metabolic pathway using graph property, Chemical Functional Group and Chemical Structural Set,” Current Bioinformatics, vol. 8, pp. 200–207, 2013.
- Y. Zhang, C. Ding, and T. Li, “Gene selection algorithm by combining reliefF and mRMR,” BMC Genomics, vol. 9, no. 2, article S27, 2008.
- H. Mohabatkar, M. Mohammad Beigi, and A. Esmaeili, “Prediction of GABAA receptor proteins using the concept of Chou's pseudo-amino acid composition and support vector machine,” Journal of Theoretical Biology, vol. 281, no. 1, pp. 18–23, 2011.
- J. B. O. Mitchell, “The relationship between the sequence identities of alpha helical proteins in the PDB and the molecular similarities of their ligands,” Journal of Chemical Information and Computer Sciences, vol. 41, no. 6, pp. 1617–1622, 2001.
- A. Schuffenhauer, P. Floersheim, P. Acklin, and E. Jacoby, “Similarity metrics for ligands reflecting the similarity of the target proteins,” Journal of Chemical Information and Computer Sciences, vol. 43, no. 2, pp. 391–405, 2003.
- M. Kanehisa, S. Goto, M. Furumichi, M. Tanabe, and M. Hirakawa, “KEGG for representation and analysis of molecular networks involving diseases and drugs,” Nucleic Acids Research, vol. 38, no. 1, Article ID gkp896, pp. D355–D360, 2009.
- S. Wedel, L. Hudak, J.-M. Seibel et al., “Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis,” BMC Cancer, vol. 11, article 375, 2011.
- “Drug combination can extend life for men with prostate cancer,” FDA Consumer, vol. 38, no. 4, 2004.
- M. Danquah, F. Li, C. B. Duke III, D. D. Miller, and R. I. Mahato, “Micellar delivery of bicalutamide and embelin for treating prostate cancer,” Pharmaceutical Research, vol. 26, no. 9, pp. 2081–2092, 2009.
- M. J. A. de Jonge and J. Verweij, “Multiple targeted tyrosine kinase inhibition in the clinic: all for one or one for all?” European Journal of Cancer, vol. 42, no. 10, pp. 1351–1356, 2006.
- M. J. Renan, “How many mutations are required for tumorigenesis? Implications from human cancer data,” Molecular Carcinogenesis, vol. 7, no. 3, pp. 139–146, 1993.
- A. A. Borisy, P. J. Elliott, N. W. Hurst, et al., “Systematic discovery of multicomponent therapeutics,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, pp. 7977–7982, 2003.
- B. B. Aggarwal, D. Danda, S. Gupta, and P. Gehlot, “Models for prevention and treatment of cancer: problems vs promises,” Biochemical Pharmacology, vol. 78, no. 9, pp. 1083–1094, 2009.
- G. R. Zimmermann, J. Lehár, and C. T. Keith, “Multi-target therapeutics: when the whole is greater than the sum of the parts,” Drug Discovery Today, vol. 12, no. 1-2, pp. 34–42, 2007.
- P. Schlatter, H. Gutmann, and J. Drewe, “Primary porcine proximal tubular cells as a model for transepithelial drug transport in human kidney,” European Journal of Pharmaceutical Sciences, vol. 28, no. 1-2, pp. 141–154, 2006.
- C. T. Supuran, “Carbonic anhydrases: novel therapeutic applications for inhibitors and activators,” Nature Reviews Drug Discovery, vol. 7, no. 2, pp. 168–181, 2008.
- Q. T. Tran, L. Xu, V. Phan et al., “Chemical genomics of cancer chemopreventive dithiolethiones,” Carcinogenesis, vol. 30, no. 3, pp. 480–486, 2009.
- Y. Mali and N. Zisapel, “A novel decoy that interrupts G93A-superoxide dismutase gain of interaction with malate dehydrogenase improves survival in an amyotrophic lateral sclerosis cell model,” Journal of Medicinal Chemistry, vol. 52, no. 17, pp. 5442–5448, 2009.
- W. F. Eanes, T. J. S. Merritt, J. M. Flowers, S. Kumagai, and C.-T. Zhu, “Direct evidence that genetic variation in glycerol-3-phosphate and malate dehydrogenase genes (Gpdh and Mdh1) affects adult ethanol tolerance in Drosophila melanogaster,” Genetics, vol. 181, no. 2, pp. 607–614, 2009.
- S.-M. Mu, X.-H. Ji, B. Ma, H.-M. Yu, and X.-J. Li, “Differential protein analysis in rat renal proximal tubule epithelial cells in response to acetazolamide and its relation with the inhibition of AQP1,” Acta Pharmaceutica Sinica, vol. 38, no. 3, pp. 169–172, 2003.
- B. Gourbal, N. Sonuc, H. Bhattacharjee et al., “Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin,” The Journal of Biological Chemistry, vol. 279, no. 30, pp. 31010–31017, 2004.
- M. Maharjan, S. Singh, M. Chatterjee, and R. Madhubala, “Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani,” American Journal of Tropical Medicine and Hygiene, vol. 79, no. 1, pp. 69–75, 2008.
- Y.-Y. Qi, K. Liu, J. Zhang, K. Li, J.-J. Ren, and P. Lin, “Synergic effect of Na(+)-K(+) ATPaseB1 and adriamycin on inhibition of cell proliferation and reversal of drug resistance in breast cancer MCF-7 cells,” Ai Zheng, vol. 28, no. 8, pp. 861–867, 2009.
- M. J. Keiser, V. Setola, J. J. Irwin et al., “Predicting new molecular targets for known drugs,” Nature, vol. 462, no. 7270, pp. 175–181, 2009.
- J. T. Sanderson, “The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals,” Toxicological Sciences, vol. 94, no. 1, pp. 3–21, 2006.
- E. Baston and F. R. Leroux, “Inhibitors of Steroidal cytochrome P450 enzymes as targets for drug development,” Recent Patents on Anti-Cancer Drug Discovery, vol. 2, no. 1, pp. 31–58, 2007.
- E. K. Nickerson, T. E. West, N. P. Day, and S. J. Peacock, “Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia,” The Lancet Infectious Diseases, vol. 9, no. 2, pp. 130–135, 2009.
- B. P. Howden, C. R. E. McEvoy, D. L. Allen et al., “Evolution of multidrug resistance during staphylococcus aureus infection involves mutation of the essential two component regulator WalKR,” PLoS Pathogens, vol. 7, no. 11, Article ID e1002359, 2011.
- G. V. Borzillo and B. Lippa, “The Hedgehog signaling pathway as a target for anticancer drug discovery,” Current Topics in Medicinal Chemistry, vol. 5, no. 2, pp. 147–157, 2005.
- K. P. Olive, M. A. Jacobetz, C. J. Davidson et al., “Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer,” Science, vol. 324, no. 5933, pp. 1457–1461, 2009.
- Y. Chen, M. Bieber, N. Bhat, and N. N. H. Teng, “Hedgehog signaling regulates drug sensitivity by targeting ABC transporters in epithelial ovarian cancer (EOC),” Cancer Research, vol. 72, 2012, Abstract 3068.
- G. W. Yip, M. Smollich, and M. Götte, “Therapeutic value of glycosaminoglycans in cancer,” Molecular Cancer Therapeutics, vol. 5, no. 9, pp. 2139–2148, 2006.
- H. Bischoff, “Pharmacology of α-glucosidase inhibition,” European Journal of Clinical Investigation, vol. 24, pp. 3–10, 1994.
- H. S. Yee and N. T. Fong, “A review of the safety and efficacy of acarbose in diabetes mellitus,” Pharmacotherapy, vol. 16, no. 5, pp. 792–805, 1996.